diplomsko delo
Abstract
Farmacevtska embalaža je embalaža pakiranja farmacevtskih pripravkov, ki jo je treba načrtovati v skladu s predpisanimi zahtevami, njihovo kakovost pa nadzorovati v skladu z vnaprej določenimi specifikacijami. Pri izbiri ustreznega materiala moramo biti previdni, da ta ob stiku z zdravilom ne spremeni njegovih lastnosti, kot so aktivnost, kakovost in čistost.
Recikliranje aluminijevih izdelkov je ključno vprašanje razvoja tega trga, predvsem zaradi velikih ekonomskih prihrankov v primerjavi s stroški nabave oz. proizvodnje primarnega aluminija. Najzanimivejši vidik recikliranja aluminija je velik prihranek energije v primerjavi s stroški energije za pretvorbo boksita in glinice v primarni aluminij. Enaka količina sekundarnega aluminija, proizvedenega iz reciklirane kovine, porabi približno 5 % energije v primerjavi s primarno proizvodnjo aluminija.
Namen diplomskega dela je bil preučiti vrste aluminijaste embalaže, ki se pojavlja v farmacevtski industriji, s poudarkom na blistrih, tj. več vrst predhodno oblikovane embalaže, običajno iz plastike ali aluminija.
Po opravljenih poskusih smo primerjali izkoristke posameznih taljenj sekundarnih surovin, ohlajevalne krivulje posameznih vzorcev, segrevalne in ohlajevalne krivulje DSC ter rezultate rentgenske fluoroscenčne spektroskopije. Rezultati so pokazali, da taljenje samega sekundarnega aluminijevega prahu ni učinkovito, saj so izkoristki prenizki. Najvišji izkoristek taljenja smo dosegli pri taljenju večjih kosov sekundarnega aluminija, pomešanega s sekundarnim aluminijevim prahom.
Keywords
reciklaža;sekundarni aluminij;farmacevtska embalaža;blister;termična analiza;
Data
Language: |
Slovenian |
Year of publishing: |
2020 |
Typology: |
2.11 - Undergraduate Thesis |
Organization: |
UL NTF - Faculty of Natural Sciences and Engineering |
Publisher: |
[R. Zupančič] |
UDC: |
669 |
COBISS: |
34584323
|
Views: |
417 |
Downloads: |
83 |
Average score: |
0 (0 votes) |
Metadata: |
|
Other data
Secondary language: |
English |
Secondary title: |
recycling of secondary aluminium from pharmaceutical packaging |
Secondary abstract: |
Pharmaceutical packaging is the packaging of pharmaceutical preparations, which must be designed in accordance with the prescribed requirements, and their quality must be controlled in accordance with predetermined specifications. When choosing the appropriate material, we must be careful that it does not change its properties, such as activity, quality and purity, upon contact with the drug.
Recycling of products made from aluminum is the crucial question when it come to the development of the market, primarily because of the great economic benefits when compared to buying or producing the primary aluminum. The most interesting aspect of aluminum recycling is the large energy savings compared to the energy costs of converting bauxite and alumina to primary aluminum. The same amount of secondary aluminum produced from recycled metal consumes about 5% of energy compared to primary aluminum production.
The purpose of the diploma thesis was to examine the types of aluminum packaging that occurs in the pharmaceutical industry, with an emphasis on blisters, ie. several types of pre-formed packaging, usually made of plastic or aluminum.
After the experiments, we compared the efficiencies of individual melts of secondary raw materials, the cooling curves of individual samples, the heating and cooling curves of DSC, and the results of X-ray fluorescence spectroscopy. The results showed that the melting of the secondary aluminum powder alone is not efficient as the efficiencies are too low. The highest melting efficiency was achieved by melting larger pieces of secondary aluminum mixed with secondary aluminum powder. |
Secondary keywords: |
recycling;secondary aluminium;pharmaceutical packaging;blister pack;thermal analysis; |
Type (COBISS): |
Bachelor thesis/paper |
Study programme: |
0 |
Embargo end date (OpenAIRE): |
1970-01-01 |
Thesis comment: |
Univ. v Ljubljani, Naravoslovnotehniška fak., Oddelek za materiale in metalurgijo |
Pages: |
XII, 39 f. |
ID: |
12046423 |